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Abstract
Since the outbreak of coronavirus disease 2019 (COVID-19) in December 2019, an epidemic has
spread rapidly worldwide. COVID-19 is caused by the highly infectious severe acute respiratory
syndrome coronavirus-2. A 42-year-old woman presented to hospital who was suffering from
epigastric discomfort and dyspepsia for the past 5 days. Before the onset of symptoms, she was
healthy, and had no travel history to Wuhan or contact with laboratory-confirmed COVID-19
cases. An examination showed chronic superficial gastritis with erosion and esophagitis. Enhanced
magnetic resonance imaging of the abdomen showed a lesion in the right lower lobe of the lungs.
Chest computed tomography showed multiple ground-glass opacity in the lungs. Reverse
transcription-polymerase chain reaction was negative for severe acute respiratory syndrome
coronavirus-2. There was no improvement after antibiotic treatment. Polymerase chain reaction
performed 2 days later was positive and she was diagnosed with COVID-19. After several days of
antiviral and symptomatic treatments, her symptoms improved and she was discharged. None of
the medical staff were infected. Clinical manifestations of COVID-19 are nonspecific, making
differentiating it from other diseases difficult. This case shows the sequence in which symptoms
developed in a patient with COVID-19 with gastrointestinal symptoms as initial manifestations.
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Background
Beginning in December 2019, there was an
outbreak of pneumonia of an unknown
cause in Wuhan, China that was related
to the new coronavirus severe acute respi-
ratory syndrome coronavirus-2 (SARS-
CoV-2).1,2 Coronavirus disease 2019
(COVID-19) infection has spread world-
wide, with almost 2470,000 people infected
as of 23 April 2020.3 The spread of COVID-
19 has caused a large amount of disruptions
to standard hospital services.4 COVID-19
has the main symptoms of fever, fatigue,
dry cough, nasal congestion, runny nose,
and diarrhea.5,6 Some patients experience
dyspnea and hypoxemia. In severe cases,
patients may experience acute respiratory
distress syndrome and viral septic shock.7
A smaller percentage of patients with
COVID-19 have abdominal discomfort as
the first symptom compared with patients
who are infected by SARS-CoV and
Middle East respiratory syndrome corona-
virus.8–10 We report a case of a patient who
presented to hospital with abdominal dis-
comfort and describe how the patient was
diagnosed.
Case presentation
On 22 January 2020, a 42-year-old woman
with no history of disease presented to
Ningbo First Hospital (Zhejiang, China).
She suffered from upper abdominal discom-
fort, including belching, which had per-
sisted for 5 days. She did not report the
common COVID-19 symptoms and had
not traveled to Wuhan or other endemic
areas of COVID-19. She was otherwise
healthy, with no history of thoracic, cardio-
vascular, or abdominal diseases. Endoscopy
showed chronic superficial gastritis with
erosion and esophagitis. An abdominal
computed tomography (CT) scan showed
intrahepatic nodules and no lung infection
on 23 January (Figure 1a and b). She was
diagnosed with gastritis, dyspepsia, and
liver tumors, and was treated with omepra-
zole, pancreatin, and rebamipide for 3 days.
Enhanced magnetic resonance imaging
of the abdomen performed on 26 January
showed a lesion in the right lower lobe of
the lungs (Figure 1c and d). CT scans per-
formed on the same day showed multiple
ground-glass opacities in the lungs (Figure
2a, b and c). She was diagnosed as having
pneumonia and was referred to the respira-
tory clinic for treatment.
On 23 January, she began to experience
fever and a runny nose. In consideration of
the new scan results and the fever, she was
transferred for the second time to the fever
clinic on 26 January. Her body temperature
was 37.4C. A complete blood count
showed a white blood cell count of
5300 cells/mm3, with 69.4% neutrophils,
22.5% lymphocytes, and 7.9% monocytes.
The C-reactive protein level was 5.08mg/L.
Liver function, and creatine kina-
se and lactate dehydrogenase levels were
within normal limits.
To treat pneumonia, we empirically
started ceftriaxone 2.0 g once daily and
levofloxacin 0.4 g once daily. Reverse
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Figure 2. (a–c) Computed tomographic images show multiple ground-glass opacities in the lungs on
26 January 2020.
Figure 1. (a, b) Abdominal computed tomographic images taken on 23 January 2020. (c, d) Abdominal
enhanced magnetic resonance images taken on 26 January 2020, which show a lesion in the right lower lobe
of the lungs.
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transcription- polymerase chain reaction
(RT-PCR) using a throat swab sample
was performed on 27 January, but the
result was negative for SARS-CoV-2. The
Ningbo First Hospital response team decid-
ed that a second RT-PCR assay was
required to exclude COVID-19. The patient
was persuaded to return to the hospital and
tested positive for SARS-CoV-2 with a
throat swab specimen by RT-PCR on 29
January. Therefore, her diagnosis was con-
firmed as COVID-19 in accordance with the
Diagnosis and Treatment Guideline of the
National Health Committee of China.11
The patient was treated with Lianhua
Qingwen capsules 16.8 g three times daily,
umifenovir 200mg three times daily, and
lopinavir and ritonavir tablets 600mg
twice daily for 2 days. She was transferred
to Ningbo No. 2 Hospital on 30 January.
She was then treated with moxifloxacin,
umifenovir, lopinavir, and ritonavir tablets,
interferon-2a, and thymosin. After several
days of symptomatic treatment, cough and
suffocation in the chest gradually subsided.
A chest CT scan showed major improve-
ment. RT-PCR for SARS-CoV-2 was neg-
ative twice from throat swab specimens on
5 and 6 February 2020 and once with a
rectal swab specimen on 6 February 2020.
In accordance with the guidelines, the
patient was clear of SARS-CoV-2 and was
discharged from the hospital on 6 February
2020.7
Discussion and conclusions
The main symptoms of COVID-19 are
fever, dry cough, expectoration, and
fatigue. Some of these patients present
with anorexia, diarrhea, nausea, and vom-
iting.12,13 Our previous study reported the
symptoms of 91 patients with COVID-19
in whom 71.43% had fever, 60.44%
reported a dry cough, 32.97% reported
expectoration, and 23.08% had diarrhea.
Asymptomatic infections were also
reported.14,15 The current patient was a
middle-aged woman with no epidemiologi-
cal history of COVID-19. She did not have
Figure 3. Angiotensin-converting enzyme 2 (ACE-2) mRNA and protein expression in normal tissues
based on the Human Protein Atlas database (https: //www.proteinatlas.org/ENSG00000130234-ACE2).
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fever or dry cough, which are the
two most common COVID-19 symptoms.
Gastrointestinal symptoms were the first
manifestations for COVID-19 in this case.
A mechanism for COVID-19 first mani-
festing as gastrointestinal symptoms has
been identified. A recent study showed
that the spike (S) glycoprotein of SARS-
CoV-2 is responsible for mediating viral
cell membrane and host membrane fusion
during infection.16 Angiotensin-converting
enzyme 2 has been identified as a functional
receptor for SARS-CoV-2, which is similar
to the sequence of SARS-CoV.1,17,18 On the
basis of angiotensin-converting enzyme 2
mRNA and protein expression in normal
tissue as shown in the Human Protein
Atlas database (https: //www.proteinatlas.
org/ENSG00000130234-ACE2) (Figure 3),
we speculate that angiotensin-converting
enzyme 2 is not only expressed in lung
cells, but also highly expressed in epithelial
cells of the digestive tract. Therefore, the
digestive system is a potential route of
infection.19 This explains why gastrointesti-
nal symptoms can be the first manifesta-
tions of COVID-19.
The clinical manifestations of COVID-
19 are common to many diseases. When
the first manifestations of COVID-19
are gastrointestinal symptoms, the process
of being diagnosed with COVID-19 is
extended and patients may transmit this
disease to many others while they seek
treatment. Before the positive diagnosis
of COVID-19, our patient had been treated
at the Internal Medicine Department,
Hepatological Surgery Department,
Digestive Department, Respiratory
Department, and fever clinic. She under-
went a series of examinations, including
abdominal enhanced magnetic resonance
imaging, a chest CT scan, and electronic
gastroscopy. Seventeen medical staff in
our hospital had to be isolated for 14 days
following her positive diagnosis.
Fortunately, none of the medical staff
were infected, which could have been a
result of the strict measures applied to pre-
vent nosocomial infection.
COVID-19 can first manifest as nonspe-
cific symptoms and lead to a delayed diag-
nosis, with the possibility of nosocomial
infections. Medical staff should take meas-
ures to prevent being infected by patients
with COVID-19 who are asymptomatic or
have nonspecific symptoms.
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